Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 3Venous Thromboembolism 2Urinary Bladder Neoplasms 1Sarcoma 1Rectal Diseases 1Prostatic Neoplasms 1Polycythemia Vera 1Ovarian Neoplasms 1Neoplasms by Site 1Myeloproliferative Disorders 1Intestinal Neoplasms 1Intestinal Diseases 1Hematuria 1Hematoma 1Gastrointestinal Neoplasms 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Endometrial Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Colorectal Neoplasms 1Colonic Diseases 1Bone Neoplasms 1Barrett Esophagus 1

Interventions

Medroxyprogesterone Acetate 3semaglutide 1pazopanib 1palbociclib 1olaparib 1lenvatinib 1fluciclovine F-18 1ferrous gluconate 1dostarlimab 1Watchful Waiting 1Sunitinib 1Specimen Handling 1Resistance Training 1Progestins 1Observation 1Nutrition Assessment 1Metformin 1Megestrol Acetate 1Magnetic Resonance Spectroscopy 1LY 353381 1Indocyanine Green 1Hysteroscopy 1High-Energy Shock Waves 1Estrogen Replacement Therapy 1Biomarkers 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Endometrial Neoplasms × Aspirin × Clear all
NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Mayo Clinic

Phase 4 Not yet recruiting
25 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡